STRATA Skin Sciences (NASDAQ:SSKN) Issues Quarterly Earnings Results, Misses Estimates By $0.73 EPS

STRATA Skin Sciences (NASDAQ:SSKN) issued its quarterly earnings data on Thursday. The medical device company reported ($1.13) EPS for the quarter, missing analysts’ consensus estimates of ($0.40) by ($0.73), Zacks reports. STRATA Skin Sciences had a negative return on equity of 69.33% and a negative net margin of 28.72%. The company had revenue of $33.56 million for the quarter, compared to the consensus estimate of $9.03 million.

STRATA Skin Sciences Stock Down 0.7 %

STRATA Skin Sciences stock opened at $2.69 on Friday. STRATA Skin Sciences has a fifty-two week low of $2.51 and a fifty-two week high of $5.90. The company has a debt-to-equity ratio of 1.62, a quick ratio of 0.94 and a current ratio of 1.13. The firm’s 50-day simple moving average is $2.75 and its 200 day simple moving average is $2.91. The stock has a market cap of $11.22 million, a PE ratio of -1.01 and a beta of 1.32.

Wall Street Analysts Forecast Growth

Separately, Maxim Group assumed coverage on STRATA Skin Sciences in a research report on Thursday, February 27th. They issued a “buy” rating and a $6.00 price target for the company.

STRATA Skin Sciences Company Profile

STRATA Skin Sciences, Inc, a medical technology company, develops, commercializes, and markets products for the treatment of dermatologic conditions in the United States, Europe, the Middle East, Asia, Australia, South Africa, and Central and South America. The company operates in two segments, Dermatology Recurring Procedures and Dermatology Procedures Equipment.